Everything you need to know about the new Covid variant
Sep 5, 2023
15:49
auto_awesome Snipd AI
Discussion on the government's response to the new variant, current state of testing and surveillance, the emergence of the BA 2.86 variant and its comparison to Omicron, availability and potential cost of private COVID vaccines in the UK, concerns over vaccine costs and importance of vaccination in preventing COVID and long COVID.
Read more
AI Summary
AI Chapters
Episode notes
auto_awesome
Podcast summary created with Snipd AI
Quick takeaways
The emergence of the new variant, BA 2.86, has prompted the UK government to bring forward the winter vaccination program and roll out Covid vaccines alongside the flu vaccine.
There is interest in making Covid vaccines available for private purchase in the UK, but concerns exist about high prices exacerbating inequalities and hindering access for eligible individuals.
Deep dives
Concerns about the new Covid variant
There is cautiousness and anxiety about facing another winter of infections with a new variant of Covid due to the lack of surveillance and situational awareness. Scientists are worried about the uncertainty of Covid's seasonal patterns and the potential pressure on the NHS during the winter. The emergence of the new variant, BA 2.86, has prompted the government to bring forward the winter vaccination program and roll out Covid vaccines alongside the flu vaccine.
Understanding the BA 2.86 variant
The BA 2.86 variant, a descendant of the Omicron sublineage, has raised concerns due to its numerous mutations. It is suspected to have incubated in an immunocompromised patient, allowing for significant mutations. The variant has spread to multiple countries, including the UK and USA. While there is some worry about the variant's ability to evade antibody protection, T-cell responses could still help mitigate severe disease. Countries with dense populations and low vaccination rates are at higher risk.
Availability of private Covid vaccines
Currently, Covid vaccines cannot be obtained privately in the UK. The Joint Committee on Vaccination and Immunization has made vaccines available to specific groups, such as individuals over 65, frontline healthcare workers, and clinically vulnerable individuals. There is interest in making the vaccines available for private purchase, although contractual commitments and regulatory factors have not made it possible yet. There are concerns that high prices for private vaccines could exacerbate inequalities and hinder access for those who are eligible but unable to afford them.
The UK Health Security Agency has announced plans to bring forward its autumn Covid-19 vaccination programme, and scale up testing and surveillance, after the emergence of the BA.2.86 variant. Madeleine Finlay and Ian Sample discuss where current infection rates stand, the characteristics of the new variant, and how prepared the UK is for a new wave. Help support our independent journalism at theguardian.com/sciencepod
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode